HBG1 | Hemoglobin, gamma A | | | | | | Tissue enriched |
SIGLEC6 | Sialic acid binding Ig-like lectin 6 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HBG2 | Hemoglobin, gamma G | Disease related genes Plasma proteins
| | | | | Tissue enriched |
GCM1 | Glial cells missing homolog 1 (Drosophila) | Transcription factors
| | | | | Tissue enriched |
HSD17B1 | Hydroxysteroid (17-beta) dehydrogenase 1 | Enzymes
| | | | | Tissue enriched |
NOTUM | Notum pectinacetylesterase homolog (Drosophila) | Predicted secreted proteins
| | | | | Tissue enriched |
CGA | Glycoprotein hormones, alpha polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANKRD33 | Ankyrin repeat domain 33 | | | | | | Tissue enriched |
ERVW-1 | Endogenous retrovirus group W, member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC52A1 | Solute carrier family 52 (riboflavin transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CGB2 | Chorionic gonadotropin, beta polypeptide 2 | Predicted secreted proteins
| | | | | Tissue enriched |
EGFL6 | EGF-like-domain, multiple 6 | Predicted secreted proteins
| | | | | Tissue enriched |
HTRA4 | HtrA serine peptidase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CXorf67 | Chromosome X open reading frame 67 | | | | | | Group enriched |
C4orf26 | Chromosome 4 open reading frame 26 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
GH1 | Growth hormone 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
TRIM60 | Tripartite motif containing 60 | | | | | | Group enriched |
FBN2 | Fibrillin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DLK1 | Delta-like 1 homolog (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PAEP | Progestagen-associated endometrial protein | Predicted secreted proteins
| | | | | Group enriched |
AC096582.1 | Uncharacterized protein | | | | | | Tissue enriched |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | | | | | | Group enriched |
IL1RL1 | Interleukin 1 receptor-like 1 | Candidate cardiovascular disease genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
LIN28B | Lin-28 homolog B (C. elegans) | | | | | | Tissue enriched |
PROK1 | Prokineticin 1 | Predicted secreted proteins
| | | | | Group enriched |
TAC3 | Tachykinin 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
ADAMTS18 | ADAM metallopeptidase with thrombospondin type 1 motif, 18 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
AQPEP | Aminopeptidase Q | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CHAT | Choline O-acetyltransferase | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
GNGT1 | Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 | RAS pathway related proteins
| | | | | Tissue enriched |
HGF | Hepatocyte growth factor (hepapoietin A; scatter factor) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
MAGEA8 | Melanoma antigen family A, 8 | | | | | | Tissue enriched |
MMP11 | Matrix metallopeptidase 11 (stromelysin 3) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
EBI3 | Epstein-Barr virus induced 3 | Predicted secreted proteins
| | | | | Tissue enriched |
GPR32 | G protein-coupled receptor 32 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
PRL | Prolactin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
RTL1 | Retrotransposon-like 1 | Predicted membrane proteins
| | | | | Group enriched |
SLC13A4 | Solute carrier family 13 (sodium/sulfate symporter), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SPP1 | Secreted phosphoprotein 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
VGLL1 | Vestigial like 1 (Drosophila) | | | | | | Tissue enriched |
AC079341.1 | Uncharacterized protein | | | | | | Tissue enriched |
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
LIPG | Lipase, endothelial | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PHOSPHO1 | Phosphatase, orphan 1 | Enzymes
| | | | | Group enriched |
SLC6A2 | Solute carrier family 6 (neurotransmitter transporter), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |